Filing Flows

Filing Flows › Vycor Medical (VYCO) › Q1 2026

Vycor Medical (VYCO) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 15, 2026

Vycor Medical (VYCO) reported revenue of $459K for the first quarter 2026 (Q1 2026), +5% from a year earlier and +10% from the quarter before. Operating margin was 10.0%, net earnings $20K (4.4% of revenue).

Revenue$459K
Year over year+5%
Quarter over quarter+10%
Operating margin10.0%
Net earnings$20K

Vycor Medical, Q1 2026: revenue $459K (+5% year over year), operating margin 10.0%, net earnings $20K, operating cash flow $99K. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$459K+10%+5%
Gross profit$375K+12%+5%
Operating profit$46K——
Net earnings$20K——
Operating cash flow$99K+153%—

What changed

Revenue was $459K in Q1 2026, up 5% year over year and up 10% from the previous quarter. Vycor Medical Inc was the largest line at 96% of revenue. Vycor Medical Inc added $22K year over year (up 5%), 99% of the total change.

Gross margin was 81.8%, down 0.3 points from Q1 2025. Operating profit was $46K, a 10.0% margin (up 12.9 points year over year). Operating expenses fell 11% while revenue rose 5%. Net earnings were $20K. The effective tax rate was -0.1%.

Operating cash flow was $99K, 494% of net earnings. Non-cash charges added back $14K of depreciation and amortization. Working capital and other items added $65K.

Questions

What was Vycor Medical's revenue in the first quarter 2026?

Vycor Medical (VYCO) reported revenue of $459K for the first quarter 2026 (Q1 2026), +5% from a year earlier and +10% from the quarter before.

Was Vycor Medical profitable in the first quarter 2026?

Operating profit was $46K (10.0% of revenue) and net earnings $20K.

Open the interactive Sankey →

Source: Vycor Medical 10-Q on SEC EDGAR.